Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of talc-free compound alpha-keto acid tablet and its preparation process

A technology of ketoacid tablets and talc powder, which is applied in the field of medicine, can solve the problems affecting inter-batch variability, small quality, poor quality uniformity, etc., and achieves the effects of ensuring inter-batch stability, preventing interaction and ensuring stability.

Active Publication Date: 2015-09-30
SHENYANG PHARMA UNIVERSITY +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] 1. Since the ingredients of the main ingredient are relatively complex, and the calcium ketoacid component is highly viscous, in the process of mixing wet granulation, when the water contained in the wetting agent is too large, the wetting agent received by the main ingredient will be affected under the premise of uniform mixing. The degree of humidity will be different, resulting in differences in the bulkiness and bulk density of dry granules formed after drying, which will affect the disintegration time and then affect the batch-to-batch variability
[0007] 2. Calcium ketoacid component is highly viscous, and if a little more binder is added, there will be serious agglomeration phenomenon, which cannot be sieved and granulated; the amino acid component is less viscous, and the appearance of adding more or less binder has no obvious change
[0010] Patent 200810224131.2 discloses a method for preparing compound α-ketoacid dispersible tablets. This method is prepared by mixing wet granulation. The drug is unstable during storage, and the content of related substances easily exceeds the standard
[0011] Patent 201110437147 discloses a compound α-ketoacid tablet and its preparation process, which adopts the process of separating the acidic and alkaline components in the main drug and wet granulation. The acidic components only include L-threonine and L-tryptophan The three components of acid and L-tyrosine have very small mass. Compared with the 7 kinds of alkaline components with too large mass, the mass uniformity is very poor. When the two parts are finally mixed, they cannot be mixed evenly
Moreover, its disintegrating agent only adopts internal addition method, and its disintegration is not particularly ideal.
In addition, 10-12mg of talcum powder is added to the prescription, which may have potential carcinogenic effects when taken by patients
[0012] Patent 201010193155 discloses a compound preparation for treating chronic kidney disease and its preparation method. Polyethylene glycol is added to the prescription as an anti-adhesive agent for the calcium ketoacid part, but polyethylene glycol also acts as an adhesive in it. Composition, when the pressure is high in the actual tableting process, the sticking phenomenon will be very serious, and the amount of polyethylene glycol can be appropriately reduced
In addition, the amount of talcum powder in the prescription has reached 33mg. If there is asbestos in the talcum powder, it will expose the problem of drug safety.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of talc-free compound alpha-keto acid tablet and its preparation process
  • A kind of talc-free compound alpha-keto acid tablet and its preparation process
  • A kind of talc-free compound alpha-keto acid tablet and its preparation process

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Below in conjunction with embodiment do further explanation. But this is only an example, and the content of the present invention is not limited thereto. Embodiment 1: (provided by the present invention, separate wet granulation)

[0053] Alkaline components:

[0054]

[0055]

[0056] Slightly acidic and near-neutral components:

[0057]

[0058] Extras:

[0059]

[0060] The preparation method is:

[0061] (1) Preparation of alkaline part

[0062] Weigh α-racemic ketoisoleucine calcium, α-ketoleucine calcium, α-ketophenylalanine calcium, α-ketovaline calcium, α-racemic hydroxymethionine calcium, L - Histidine, PVPP, equal amount and mix evenly; weigh PVP, dissolve in appropriate amount of alcohol solution, prepare a binder with a concentration of 5%-15% (g / ml), add it to the mixed alkaline The main drug is made of soft materials, granulated, dried, granulated, and the alkaline part is obtained;

[0063] (2) Preparation of acidic and near-neutral pa...

Embodiment 2

[0067] Embodiment 2: (separate wet granulation, the solvent of binder is aqueous solution)

[0068] Alkaline components:

[0069]

[0070] Slightly acidic and near-neutral components:

[0071]

[0072] Extras:

[0073]

[0074] The preparation method is:

[0075] (1) Preparation of alkaline part

[0076] Weigh α-racemic ketoisoleucine calcium, α-ketoleucine calcium, α-ketophenylalanine calcium, α-ketovaline calcium, α-racemic hydroxymethionine calcium, L - Histidine, PVPP, equal amount and mix evenly; weigh PVP, dissolve in appropriate amount of aqueous solution, prepare a binder with a concentration of 5%-15% (g / ml), add it to the mixed alkaline The main drug is made of soft materials, granulated, dried, and granulated to obtain the alkaline part;

[0077] (2) Preparation of acidic and near-neutral parts

[0078] Weigh the prescribed amount of L-lysine acetate, L-threonine, L-tryptophan, L-tyrosine, pregelatinized starch, PVPP, and mix evenly in equal amounts; ...

Embodiment 3

[0080] Example 3: (separate wet granulation, only internally added disintegrant)

[0081] Alkaline components:

[0082]

[0083] Slightly acidic and near-neutral components:

[0084]

[0085] Extras:

[0086] Polyethylene glycol 10.8mg

[0087] Micronized silica gel 5.4mg

[0088] Magnesium Stearate 15mg

[0089] The preparation method is:

[0090] (1) Preparation of alkaline part

[0091] Weigh α-racemic ketoisoleucine calcium, α-ketoleucine calcium, α-ketophenylalanine calcium, α-ketovaline calcium, α-racemic hydroxymethionine calcium, L - Histidine, PVPP, equal amount and mix evenly; weigh PVP, dissolve in appropriate amount of alcohol solution, prepare a binder with a concentration of 5%-15% (g / ml), add it to the mixed alkaline The main drug is made of soft materials, granulated, dried, granulated, and the alkaline part is obtained;

[0092] (2) Preparation of acidic and near-neutral parts

[0093] Weigh the prescribed amount of L-lysine acetate, L-threonine...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a compound alpha-ketoacid tablet free of talcum powder and a preparation process thereof. The conventional preparation process is changed without adding the talcum powder; the tablet prepared by the method has good compressibility, attractive appearance, high disintegrating speed, high dissolution rate, high stability in long-term placement and high medicinal safety. Wet granulation is performed separately according to the acidic and alkaline ingredients and the mass balance ratio of main medicines, i.e., a meta-alkaline ingredient, a meta-acidic ingredient and a nearly neutral ingredient are subjected to wet granulation separately, and then mixing, tabletting and coating are performed, so that the direct contact among the ingredients is avoided, long-term stable placement can be realized and the contents of the active ingredients are guaranteed. A disintegrating agent internal and external addition method is adopted in the formula, the content of polyethylene glycol is optimized, and no talcum powder or analogs with ingredients similar to the talcum powder are included in the formula, so that the problems of agglomeration phenomenon and larger viscosity in the granulation process are solved, and the safety in medication is guaranteed.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to a compound α-keto acid tablet and a preparation process thereof, in particular to a talc-free compound α-keto acid tablet and a preparation process thereof. Background technique [0002] Chronic kidney disease is a relatively benign disease that develops slowly, but if it is not diagnosed and treated in time, it can lead to the deterioration and progression of the disease or the progression of the disease, developing into chronic renal insufficiency, renal failure, and eventually uremia. At present, its incidence is increasing, and most patients are often unaware of their condition, which seriously endangers human health. [0003] Compound α-ketoacid tablet is a drug with significant curative effect on chronic kidney disease, and it is used to prevent and treat damage caused by protein metabolism disorder caused by chronic renal insufficiency. The drug is designed with the ratio of essenti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4172A61K9/28A61P13/12A61P3/02A61K31/405A61K31/19A61K31/192A61K31/198
Inventor 刘晓红李广京王俊峰孙进陈思李冰何仲贵
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products